Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. It will be one of the world’s largest coronavirus vaccine studies so far, testing in 60,000 people. https://t.co/CWXnKXhI7Z

— The Associated Press (@AP) September 23, 2020